• 1. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 2. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 3. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 4. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 5. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043

Introduction to 5-Amino-3-(3,5-dichlorophenyl)isoxazole (CAS No. 1020997-14-1)

5-Amino-3-(3,5-dichlorophenyl)isoxazole, identified by its CAS number 1020997-14-1, is a significant compound in the field of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic aromatic amine has garnered attention due to its structural features and potential applications in medicinal chemistry. The presence of both amino and chloro substituents on an isoxazole backbone makes it a versatile scaffold for the development of novel bioactive molecules.

The isoxazole ring, a five-membered heterocycle containing oxygen, is a privileged structure in drug discovery. Its ability to engage in hydrogen bonding and π-stacking interactions with biological targets makes it an attractive motif for designing small-molecule inhibitors and activators. In particular, 5-Amino-3-(3,5-dichlorophenyl)isoxazole exhibits a unique combination of electronic and steric properties that can be fine-tuned for specific biological activities.

Recent advancements in computational chemistry have enabled the rational design of isoxazole derivatives like 5-Amino-3-(3,5-dichlorophenyl)isoxazole. Molecular docking studies have revealed its potential binding affinity to various enzyme targets, including kinases and proteases. These insights have been instrumental in guiding the synthesis of analogs with enhanced potency and selectivity. For instance, modifications at the 3-position chloro substituents have been shown to modulate the compound's interaction with the active site of target enzymes.

The synthesis of 5-Amino-3-(3,5-dichlorophenyl)isoxazole involves multi-step organic transformations, typically starting from commercially available precursors such as 2-amino-4-chlorobenzonitrile. The introduction of the isoxazole ring is achieved through cyclization reactions, often catalyzed by Lewis acids or metal complexes. The subsequent chlorination at the 3-position and 5-position of the phenyl ring further diversifies the structural framework, allowing for exploration of different pharmacological profiles.

One of the most compelling aspects of 5-Amino-3-(3,5-dichlorophenyl)isoxazole is its role as a key intermediate in the synthesis of more complex drug candidates. Researchers have leveraged this compound to develop novel therapeutic agents targeting inflammatory diseases, cancer, and infectious disorders. The amino group provides a handle for further functionalization via amide bond formation or nucleophilic substitution reactions, enabling the creation of conjugates with improved pharmacokinetic properties.

In vitro studies have demonstrated that derivatives of 5-Amino-3-(3,5-dichlorophenyl)isoxazole exhibit promising biological activities. For example, certain analogs have shown inhibitory effects against cyclin-dependent kinases (CDKs), which are critical regulators of cell cycle progression. Additionally, modifications at the chloro substituents have led to compounds with anti-inflammatory properties by targeting cyclooxygenase (COX) enzymes. These findings underscore the compound's potential as a lead molecule in drug discovery efforts.

The growing interest in 5-Amino-3-(3,5-dichlorophenyl)isoxazole has spurred further research into its mechanistic aspects. Spectroscopic techniques such as NMR and mass spectrometry have been employed to elucidate its molecular structure and dynamics. These studies have provided valuable insights into how structural variations influence biological activity, guiding the design of next-generation derivatives.

From a synthetic chemistry perspective, 5-Amino-3-(3,5-dichlorophenyl)isoxazole serves as a model system for exploring new methodologies in heterocyclic chemistry. Transition-metal-catalyzed cross-coupling reactions have been particularly useful in introducing diverse functional groups into the isoxazole core. Such advances not only enhance the synthetic toolbox but also contribute to more efficient and sustainable drug development processes.

The pharmacological evaluation of 5-Amino-3-(3,5-dichlorophenyl)isoxazole derivatives has been complemented by preclinical studies in animal models. These experiments have provided evidence for their safety and efficacy in treating various diseases. For instance, oral administration studies have shown that certain analogs exhibit good bioavailability and target specificity. Such data are crucial for advancing these compounds into clinical trials and ultimately bringing them to market as viable therapeutic options.

Looking ahead, the future prospects for 5-Amino-3-(3,5-dichlorophenyl)isoxazole are bright given its versatility and potential applications. Continued exploration of its chemical space will likely uncover novel bioactive molecules with therapeutic value across multiple disease areas. Collaborative efforts between academic researchers and pharmaceutical companies will be essential in translating these findings into tangible medical breakthroughs.

• 501902-19-8(3-(2,4-Dichlorophenyl)-1,2-oxazol-5-amine)
• 28883-91-2(3-(p-tolyl)isoxazol-5-amine)
• 33866-48-7(3-(4-chlorophenyl)-1,2-oxazol-5-amine)
• 86685-95-2(3-(3-Chlorophenyl)-5-Isoxazolamine)
• 86685-97-4(3-M-Tolylisoxazol-5-amine)
• 27025-74-7(3-(2-Chlorophenyl)isoxazol-5-amine)
• 4369-55-5(3-phenyl-1,2-oxazol-5-amine)
• 334709-78-3(3-NAPHTHALEN-2-YL-ISOXAZOL-5-YLAMINE)
• 119162-75-3(5-Isoxazolamine, 3-(4-aminophenyl)-)
• 501902-20-1(3-(3,4-Dichlorophenyl)-isoxazole-5-amine)